M. Arihara, K. Miyata, Satoshi Iihoshi, R. Yokoyama, Ayumu Yamaoka, Yuto Suzuki, T. Mikami, M. Wanibuchi, N. Mikuni
{"title":"Cerebral Ischemic Complications of Subclavian Artery Stenting: Relationship between Lesion Location and Procedural Strategy","authors":"M. Arihara, K. Miyata, Satoshi Iihoshi, R. Yokoyama, Ayumu Yamaoka, Yuto Suzuki, T. Mikami, M. Wanibuchi, N. Mikuni","doi":"10.5797/jnet.oa.2019-0034","DOIUrl":null,"url":null,"abstract":"Objective: Clinical research demonstrating safety and security in subclavian artery stenting (SAS) is limited because treatment strategies for SAS vary greatly among institutions, operators, and clinical conditions, as no standard protocol exists. As stenotic lesions frequently occur in the proximal portion of the subclavian artery (SA), it is often difficult to stabilize the guiding catheter for stent delivery. Our purpose was to assess whether lesion location can be used to predict optimal procedural strategies. Methods: We performed a retrospective, single-center observational study on 26 consecutive patients who underwent SAS between 2004 and 2016. We categorized patients treated with SAS into two groups according to lesion location: those with lesions located less than 10 mm from the origin of the SA (Group P) and those with lesions in the distal portion (Group D). We defined a bidirectional approach via both brachial and femoral puncture as well as bilateral brachial puncture as combined access. In pull-through method, a guidewire was passed from one sheath to another. We compared Group P with Group D in terms of procedural strategy and efficacy. Results: All 26 cases were clinically successful. Asymptomatic cerebral embolism was found in 10 (48%) of 21 cases in which postoperative MRI was performed, and the number of spotty lesions was less than four in every patient. Arterial access-site complications were documented in eight patients. Two cases of late in-stent restenosis were retreated with balloon dilatation. Cases with retrograde ipsilateral vertebral artery (VA) blood flow and symptomatic lesions occurred more frequently in Group P than in Group D (79% vs. 42%; p = 0.06, 71% vs. 33%; p = 0.05, respectively). Patients in Group P were significantly more often treated with combined access (100% vs. 42%; p = 0.001), with the pull-through method (64% vs. 0%; p < 0.001) than those in Group D. The distal end of the stent was involved with the ipsilateral VA orifice more often in Group D than in Group P (50% vs. 7%; p = 0.02). Conclusion: These results demonstrate that our strategy is a safe and effective method of stenting for SA stenosis in the portion of the artery that is proximal to the aorta. We should pay special attention to the risk of arterial access-site complications.","PeriodicalId":34768,"journal":{"name":"JNET","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNET","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5797/jnet.oa.2019-0034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Clinical research demonstrating safety and security in subclavian artery stenting (SAS) is limited because treatment strategies for SAS vary greatly among institutions, operators, and clinical conditions, as no standard protocol exists. As stenotic lesions frequently occur in the proximal portion of the subclavian artery (SA), it is often difficult to stabilize the guiding catheter for stent delivery. Our purpose was to assess whether lesion location can be used to predict optimal procedural strategies. Methods: We performed a retrospective, single-center observational study on 26 consecutive patients who underwent SAS between 2004 and 2016. We categorized patients treated with SAS into two groups according to lesion location: those with lesions located less than 10 mm from the origin of the SA (Group P) and those with lesions in the distal portion (Group D). We defined a bidirectional approach via both brachial and femoral puncture as well as bilateral brachial puncture as combined access. In pull-through method, a guidewire was passed from one sheath to another. We compared Group P with Group D in terms of procedural strategy and efficacy. Results: All 26 cases were clinically successful. Asymptomatic cerebral embolism was found in 10 (48%) of 21 cases in which postoperative MRI was performed, and the number of spotty lesions was less than four in every patient. Arterial access-site complications were documented in eight patients. Two cases of late in-stent restenosis were retreated with balloon dilatation. Cases with retrograde ipsilateral vertebral artery (VA) blood flow and symptomatic lesions occurred more frequently in Group P than in Group D (79% vs. 42%; p = 0.06, 71% vs. 33%; p = 0.05, respectively). Patients in Group P were significantly more often treated with combined access (100% vs. 42%; p = 0.001), with the pull-through method (64% vs. 0%; p < 0.001) than those in Group D. The distal end of the stent was involved with the ipsilateral VA orifice more often in Group D than in Group P (50% vs. 7%; p = 0.02). Conclusion: These results demonstrate that our strategy is a safe and effective method of stenting for SA stenosis in the portion of the artery that is proximal to the aorta. We should pay special attention to the risk of arterial access-site complications.
目的:临床研究表明锁骨下动脉支架植入术(SAS)的安全性和安全性是有限的,因为SAS的治疗策略因机构、操作者和临床条件的不同而差异很大,没有标准的方案。由于狭窄病变常发生在锁骨下动脉(SA)近端,通常难以稳定支架置入的导管。我们的目的是评估病变位置是否可以用来预测最佳的手术策略。方法:我们对2004年至2016年间连续26例接受SAS治疗的患者进行了回顾性、单中心观察研究。我们根据病变位置将接受SAS治疗的患者分为两组:病变位于距SA起源小于10mm的患者(P组)和病变位于远端部分的患者(D组)。我们定义了通过肱和股动脉穿刺以及双侧肱动脉穿刺的双向入路作为联合入路。在拉通法中,导丝从一个护套传递到另一个护套。我们将P组与D组在手术策略和疗效方面进行比较。结果:26例临床均成功。21例患者术后行MRI检查,无症状脑栓塞10例(48%),点状病灶少于4例。8例患者出现动脉通路并发症。2例晚期支架内再狭窄均经球囊扩张治疗。P组出现同侧椎动脉(VA)逆行血流和症状性病变的频率高于D组(79% vs. 42%;P = 0.06, 71% vs. 33%;P = 0.05)。P组患者更常接受联合治疗(100% vs. 42%;P = 0.001),采用拉通法(64% vs. 0%;p < 0.001),与D组相比,D组支架远端累及同侧VA口的频率更高(50% vs. 7%;P = 0.02)。结论:我们的方法是治疗主动脉近端SA狭窄的一种安全有效的方法。我们应特别注意动脉通路并发症的风险。
期刊介绍:
JNET Journal of Neuroendovascular Therapy is the official journal of the Japanese Society for Neuroendovascular Therapy (JSNET). The JNET publishes peer-reviewed original research related to neuroendovascular therapy, including clinical studies, state-of-the-art technology, education, and basic sciences.